SRP4969

Epigen (EPGN) human

recombinant, expressed in E. coli, ≥98% (SDS-PAGE)

• Sinónimos: ALGV3072, EPG, EPGN, Epigen, FLJ75542, PRO9904
• Código UNSPSC: 12352202
• NACRES: NA.32

Propiedades

• origen biológico: human
• recombinante: expressed in E. coli
• Ensayo: ≥98% (SDS-PAGE)
• Formulario: lyophilized
• potencia: 150-300 ng/mL
• mol peso: ~7.9 kDa
• envase: pkg of 25 μg
• impurezas: endotoxin, tested
• Nº de acceso NCBI: Q6UW88
• Nº de acceso UniProt: Q6UW88
• Condiciones de envío: wet ice
• temp. de almacenamiento: −20°C
• Información sobre el gen: human ... EPGN(255324)

Descripción

Descripción general

The precursor EPGN (epigen) is a transmembrane glycoprotein and is widely expressed in human tissues. The precursor is cleaved to give a soluble EGF (epidermal growth factor)-like domain.
Recombinant Human epigen, produced in Escherichia coli is a single, non-glycosylated, polypeptide chain containing 72 amino acids and having a molecular mass of 7.9kDa.

Acciones bioquímicas o fisiológicas

EPGN (epigen) is a ligand for EGFR (epidermal growth factor receptor). EPGN (epigen) belongs to the EGF family and enhances proliferation in keratinocytes.

Forma física

EPGN was lyophilized from 20 mM PBS buffer pH-7.4 containing 130 mM sodium chloride.

Reconstitución

Centrifuge the vial prior to opening. Avoid freeze-thaw cycles.

Reconstitute in sterile d-H₂O not less than 100 μg/ml. For long term storage, it is recommended to add a carrier protein (0.1% HSA or BSA).